News

The Kentucky Neuroscience Clinical-Translational Research Symposium will provide basic, translational and clinical neuroscience investigators an opportunity to discuss their work, share progress and develop collaborations.

Results from a survey of more than 1,000 U.S. adults showed that while almost 80 percent of respondents were willing to volunteer for medical research, two-thirds didn't know how to get involved.

A UK neurologist who stumbled across a family with a gene mutation that can cause Lou Gehrig's Disease is merging science, medicine and family in a quest for a cure.

STAT News, a division of the Boston Globe, has published a story about the work of Dr. Edward Kasarskis and his team, who study a familial form of ALS.

A rare, genetic type of ALS seems to cluster in central Appalachia. The TRANSLATE clinical trial, led by a multidisciplinary time of clinicians and scientists, is looking for hope in an existing FDA-approved drug.

New findings from the University of Kentucky published in the Journal of Neuroscience demonstrate that there may be ways to address blood-brain barrier dysfunction in epilepsy.

Following in his father’s footsteps, Esias Bedingar came to UK in 2014 from Chad, not knowing any English at all. Since then, he has founded a nonprofit to help eradicate malaria in his home country, conducts research in neurodegenerative diseases, and will graduate with a degree in public health before attending Harvard University this fall.

A team of UK researchers have homed in on a protein, called RIT1, that may act as a master switch in the brain. A new five-year, $2.5 million grant from the National Institutes of Health will help them explore RIT1 as a possible target for treatments to counteract brain injury.

The third annual International Society of Neurogastronomy Symposium brought together experts from the worlds of food and neuroscience to explore what we eat and why.

Dr. Craig Van Horne, neurosurgeon, and Dr. George Quintero, DBS neurophysiologist at UK HealthCare's Neuroscience Institute, discuss deep brain stimulation in Sunday's Herald-Leader Your Health column.